Home > Back to Publisher > Report Information

Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles

Business Insights
January 1, 2010
221 Pages - SKU: RET2539951

Abstract Table of Contents Search inside this report Related Reports

The advent of healthcare nanotechnology has had a vast impact in the fields of drug delivery and diagnostics. The role of nanotechnology in healthcare is very important in terms of eradicating diseases, especially in terms of treating cancer. Advanced technological developments in coatings and implants using nanotechnology is expected to increase the scope of the market in various applications. This report covers different regional application markets, while evaluating them over the next five years. It provides information about the largest regional markets and factors influencing them, while defining the opportunities they present.

Nanotechnology in Healthcare
Executive summary: Market overview; Healthcare nanotechnology market dynamics; Nanomaterials & nanotools for the healthcare market; Healthcare nanotechnology application market; Company profiles
Chapter 1 Market overview: Summary; Introduction; Market definition; Healthcare nanotechnology business processes; Healthcare nanotechnology applications; Healthcare nanotechnology application prospects; Opportunity matrix; Challenge matrix; Patent analysis
Chapter 2 Healthcare nanotechnology market dynamics: Summary; Introduction; Regional markets; North America; Europe; Asia; RoW; Competitive landscape; R&D activities by applications; New product launches; Collaborations & agreements; Market drivers; Nanotechnology research initiatives in developing nations; Innovations are increasing; Reduced toxicity; Market inhibitors; Delay in commercialization; Stability and other issues; Need for particle evaluation
Chapter 3 Nanomaterials & nanotools for the healthcare market: Summary; Introduction; Nanomaterials; Nanocapsules; Drivers; Inhibitors; Opportunities; Nanoporous materials; Drivers; Opportunities; Quantum dots; Drivers; Inhibitors; Opportunities; Nanotubes; Drivers; Nanowires; Drivers; Inhibitors; Opportunities; Dendrimers; Drivers; Opportunities; Monoclonal antibodies; Drivers; Inhibitors; Opportunities; Nanocomposites; Fullerenes; Nanofilms; Drivers; Inhibitors; Opportunities; Nanotools; Nanoarrays; Drivers; Inhibitors; Opportunities; Nanobiochip; Drivers; Opportunities; Nanolithography arrays; Drivers; Inhibitors; Opportunities; Computer-assisted drug discovery; Nanomass spectrometry; Drivers; Inhibitors; Opportunities; Congruent Force Intermolecular Test (nanotype) C-FIT
Chapter 4 Healthcare nanotechnology application market: Summary; Introduction; Drug formulation and delivery; Formulation; Drivers; Inhibitors; Opportunities; Fluorescently encoded microparticles; Nanoparticulate formulation/systems; Fluoropolymers as material platforms for drug therapy; DNA nanoparticle technology to produce DNA drugs; Drug profiling using smart materials; Supercritical fluids and water based nanomaterials; Dendrimer nanotechnology products; Potential healthcare nanotechnology drug formulation application; Drug delivery; Drivers; Inhibitors; Opportunities; Nanoencapsulation using nano-device platform; Smart materials for encapsulation; Antimicrobial nanoencapsulation; Nanoscale cochlear drug delivery; Drug delivery using nanoparticles; Nanocrystals for drug delivery; Drug delivery coatings; Nanopores; Nanocomposites; Nanotransponders; Potential applications of healthcare nanotechnology drug delivery; Biocompatible implants and coatings; Drivers; Nanofibers fight immune response; Improvement in biocompatibility; Optimized coatings; Improvement in dental implants; Inhibitors; Improvement of implant depends upon coatings; Possibility of mass poisoning; Opportunities; Improved brain implants; Improvement in process for better coatings; Helpful in orthopedic devices; Surface modification; Device coating; Drivers; Inhibitors; Opportunities; Sol-gel coatings; Biocompatible nanocoatings; Nanoscale plasma coating; Light-activated antimicrobials; Silver nanoparticles; Hydrophobic coatings; Multifunctional coatings; Anti-fouling nanocoatings; Passive hydroxyapatite coating; Other protective coatings; Implants; Drivers; Opportunities; Potential biocompatible implants applications; Life support devices using novel biocompatible polymers; Stimulation electrodes using nanotechnology; Noninvasive killing of cancer cells using localized heat; Artificial vascular grafts; Bone graft substitutes; Regenerative medicine and wound care; Regenerative medicine/tissue engineering; Drivers; Inhibitors; Opportunities; Potential applications of regenerative medicines; Wound care; Drivers; Opportunities; Nanosilver gels; Nanogold gels; Diagnostics; Drivers; Improved bioassays; Earlier diagnosis and effective monitoring; Opportunities; Treatment of ovarian cancer; Development of immunoassays; Quantum dots applications; Nanoemulsions in multimodal molecular imaging and targeted therapeutics; Nanoparticles for biochemical applications; Magnetic nanoparticles for medical diagnostic imaging; Encapsulation of radioactive nanoparticle; Genome sequencing; Nanobiosensors; Nanoarray biochips; Silicon-based chips/sensors for pH and pressure; Micro- and nano-replication for point-of-use analytical applications; Nanocells; Redox enzymes; Other potential diagnostics applications; Smart card diagnostics; Novel microfluidic technologies
Chapter 5 Company profiles: Summary; Abraxis BioScience, Inc.; Company overview; Products and services; Company strategy; Access Pharmaceuticals, Inc.; Company overview; Products and services; Company strategy; AstraZeneca; Company overview; Products and services; Company strategy; AMAG Pharmaceuticals, Inc.; Company overview; Products and services; Company strategy; Aphios Corp.; Company overview; Products and services; Company strategy; Asklepios Biopharmaceutical Inc.; Company overview; Products and services; Company strategy; Capsulution Nanoscience AG; Company overview; Products and services; Company strategy; ConvaTec; Company overview; Products and services; Company strategy; Debiotech; Company overview; Products and services; Company strategy; Do-Coop Technologies Ltd.; Company overview; Products and services; Company strategy; Elan Corp.; Company overview; Products and services; Company strategy; Ferro Corp.; Company overview; Products and services; Company strategy; Flamel Technologies; Company overview; Products and services; Company strategy; GE Global Research; Company overview; Company strategy; GfE Medizintechnik GmbH; Company overview; Products and services; Company strategy; HemCon Medical Technologies, Inc.; Company overview; Company strategy; iCeutica Inc; Company overview; Products and services; Company strategy; Liquidia Technologies; Company overview; Company strategy; Luna Innovations Inc.; Company overview; Products and services; Company strategy; MagForce Nanotechnologies AG; Company overview; Products and services; Company strategy; Merck KGaA; Company overview; Products and services; Company strategy; MIV Therapeutics Inc; Company overview; Products and services; Company strategy; Nanomix; Company overview; Products and services; Company strategy; Nano Interface Technology, Inc; Company overview; Products and services; Company strategy; NanoCarrier Co., Ltd.; Company overview; Products and services; Company strategy; NanoDel Technologies; Company overview; Products and services; Company strategy; NanoHorizons Inc.; Company overview; Products and services; Company strategy; Nanoprobes, Inc.; Company overview; Products and services; Company strategy; Nanospectra Biosciences Inc.; Company overview; Products and services; Company strategy; Nanosphere, Inc.; Company overview; Products and services; Company strategy; Novartis AG; Company overview; Products and services; Company strategy; Pfizer; Company overview; Company strategy; PharmaSol GmbH; Company overview; Products and services; Company strategy; Pioneer Surgical Technology; Company overview; Products and services; Company strategy; pSivida; Company overview; Products and services; Company strategy; F. Hoffmann-La Roche Ltd.; Company overview; Products and services; Company strategy; Siemens Medical Solutions; Company overview; Products and services; Company strategy; Smith & Nephew; Company overview; Products and services; Company strategy; Starpharma Holdings Ltd.; Company overview; Products and services; Company strategy; T2 Biosystems Inc.; Company overview; Company strategy; Appendix; Patents; Glossary
List of Figures: Figure 1.1: Global healthcare nanotechnology market; Figure 1.2: Geographical patent share, 2003-08; Figure 1.3: Number of patents by region, 2003-09; Figure 1.4: Comparison of patent trends, 2004 vs 2009; Figure 2.5: Developmental strategies by major players, January 2007-November 2009; Figure 2.6: R&D activities by applications, Jan 2007-Nov 2009; Figure 2.7: New product launches, Jan 2007-Nov 2009; Figure 2.8: Collaborations & agreements by applications, Jan 2007-Nov2009; Figure 2.9: Relative importance of features of healthcare nanotechnology
List of Tables: Table 2.1: Global healthcare nanotech market, by geography ($m), 2007-14; Table 2.2: Mergers & acquisitions in healthcare nanotech market, 2007-09; Table 2.3: New product launches in healthcare nanotech market, 2007-09; Table 2.4: New product launches in healthcare nanotech market, 2007-09 (ctd); Table 2.5: R&D in healthcare nanotech market, 2007-09; Table 2.6: R&D in healthcare nanotech market, 2007-09 (ctd 1); Table 2.7: R&D in healthcare nanotech market, 2007-09 (ctd 2); Table 2.8: R&D in healthcare nanotech market, 2007-09 (ctd 3); Table 2.9: R&D in healthcare nanotech market, 2007-09 (ctd 4); Table 2.10: R&D in healthcare nanotech market, 2007-09 (ctd 5); Table 2.11: R&D in healthcare nanotech market, 2007-09 (ctd 6); Table 2.12: Collaborations & agreements in healthcare nanotech market, 2007-09; Table 2.13: Collaborations & agreements in healthcare nanotech market, 2007-09 (ctd); Table 4.14: Global healthcare nanotech drug formulation and delivery market, by product ($m), 2007-14; Table 4.15: Global healthcare nanotech drug formulation and delivery market, by geography ($m), 2007-14; Table 4.16: Global healthcare nanotechnology drug formulation market, by product ($m), 2007-14; Table 4.17: Global healthcare nanotech fluorescently encoded microparticles market, by geography ($m), 2007-14; Table 4.18: Global healthcare nanotech nanoparticulate formulation/systems market, by geography ($m), 2007-14; Table 4.19: Global healthcare nanotech fluoropolymers material platforms for drug therapy market, by geography ($m), 2007-14; Table 4.20: Global healthcare DNA nanoparticle technology to produce DNA drugs market, by geography ($m), 2007-14; Table 4.21: Global healthcare nanotech drug profiling using smart materials market, by geography ($m), 2007-14; Table 4.22: Global healthcare nanotech supercritical fluids and water based nanomaterials market, by geography ($m), 2007-14; Table 4.23: Global dendrimer nanotech products market by geography ($m), 2007-14; Table 4.24: Global healthcare nanotech drug delivery market by product ($m), 2007-14; Table 4.25: Global healthcare nanoencapsulation using nano-device platform market, by product ($m), 2007-14; Table 4.26: Global healthcare nanoencapsulation using nano-device platform market, by geography ($m), 2007-14; Table 4.27: Global market for smart materials encapsulating pharmaceuticals, by geography ($m), 2007-14; Table 4.28: Global healthcare nanotech antimicrobial nanoencapsulation, by geography ($m), 2007-14; Table 4.29: Global healthcare nanotech nanoscale cochlear drug delivery, by geography ($m), 2007-14; Table 4.30: Global healthcare nanotech drug delivery using nanoparticles market, by product ($m), 2007-14; Table 4.31: Global healthcare nanotech drug delivery using nanoparticles market, by geography ($m), 2007-14; Table 4.32: Global drug delivery using nanocrystals market, by geography ($m), 2007-14; Table 4.33: Global healthcare nanotech drug delivery coatings market, by geography ($m), 2007- 14; Table 4.34: Global healthcare nanopores market, by geography ($m), 2007-14; Table 4.35: Global healthcare nanocomposites market, by geography ($m), 2007-14; Table 4.36: Global healthcare nanotech nanotransponder market, by geography ($m), 2007-14; Table 4.37: Global healthcare nanotech biocompatible implants and coatings market, by products ($m), 2007-14; Table 4.38: Global healthcare nanotech biocompatible implants and coatings market, by geography ($m), 2007-14; Table 4.39: Global healthcare nanotech surface modification market, by geography ($m), 2007-14; Table 4.40: Global healthcare nanotech device coating market, by products ($m), 2007-14; Table 4.41: Global healthcare nanotech device coating market, by geography ($m), 2007-14; Table 4.42: Global healthcare nanotech implants market, by geography ($m), 2007-14; Table 4.43: Global healthcare nanotech regenerative medicine and wound care market, by products ($m), 2007-14; Table 4.44: Global healthcare nanotech regenerative medicine market, by product ($m), 2007-14; Table 4.45: Global healthcare nanotech wound care market, by products ($m), 2007-14; Table 4.46: Global healthcare nanotech diagnostics market, by products ($m), 2007-14; Table 4.47: Global healthcare nanotech diagnostics market, by geography ($m), 2007-14; Table 0.48: US patents; Table 0.49: US patents (ctd 1); Table 0.50: US patents (ctd 2); Table 0.51: US patents (ctd 3); Table 0.52: US patents (ctd 4); Table 0.53: US patents (ctd 5); Table 0.54: US patents (ctd 6); Table 0.55: US patents (ctd 7); Table 0.56: US patents (ctd 8); Table 0.57: US patents (ctd 9); Table 0.58: US patents (ctd 10); Table 0.59: US patents (ctd 11); Table 0.60: US patents (ctd 12); Table 0.61: US patents (ctd 13); Table 0.62: US patents (ctd 14); Table 0.63: US patents (ctd 15); Table 0.64: US patents (ctd 16); Table 0.65: US patents (ctd 17); Table 0.66: US patents (ctd 18); Table 0.67: US patents (ctd 19); Table 0.68: Europe patents; Table 0.69: Europe patents (ctd 1); Table 0.70: Europe patents (ctd 2); Table 0.71: Europe patents (ctd 3); Table 0.72: Europe patents (ctd 4); Table 0.73: Europe patents (ctd 5); Table 0.74: Europe patents (ctd 6); Table 0.75: Europe patents (ctd 7); Table 0.76: Europe patents (ctd 8); Table 0.77: Europe patents (ctd 9); Table 0.78: Europe patents (ctd 10); Table 0.79: Europe patents (ctd 11); Table 0.80: Japan patents; Table 0.81: Japan patents (ctd 1)

Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service